Exploring bioflavonoids as novel antivirals against Chikungunya virus / Rafidah Lani
Chikungunya virus (CHIKV) is a mosquito-borne virus that recently has been classified as a Category C pathogen by National Institute of Allergy and Infectious Diseases (NIAID). This alphavirus causes several clinical features similar to dengue virus infection, except polyarthritis and tenosynovitis,...
Saved in:
Main Author: | Rafidah, Lani |
---|---|
Format: | Thesis |
Published: |
2016
|
Subjects: | |
Online Access: | http://studentsrepo.um.edu.my/7063/4/rafidah.pdf http://studentsrepo.um.edu.my/7063/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regulation of toll-like receptor-mediated innate immune response in chikungunya virus-infected and Fisetin-treated human hepatocellular carcinoma Huh7 cells / Rafidah Lani
by: Rafidah , Lani
Published: (2022) -
Antiviral activity of four types of bioflavonoid against dengue virus type-2.
by: Zandi, K., et al.
Published: (2011) -
Antiviral activity of four types of bioflavonoid against dengue virus type-2
by: Zandi, Keivan, et al.
Published: (2011) -
Antiviral activity of hesperetin and naringenin against Chikungunya virus replication in vitro / Azin Ahmadi
by: Azin, Ahmadi
Published: (2018) -
Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection
by: Oo, Adrian, et al.
Published: (2018)